Skip to main content

MoneyWorks4Me

Venus Remedies informs about press release

20 Sep 2023 Evaluate

Venus Remedies has informed that it enclosed a press release being issued by the Company titled ‘Venus Remedies extends Its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1872.30
Dr. Reddys Labs. 1396.00
Cipla 1420.00
Lupin 1968.95
Zydus Lifesciences 1195.00
View more..